Immune Pharmaceuticals Files for Chapter 11 Protection Feb 19, 2019 07:38AM
Immune Pharmaceuticals Engages Extera Partners to Pursue Bertilimumab Strategic Transaction Dec 18, 2018 08:30AM
UPDATE -- Immune Pharmaceuticals Announces Adjournment of Special Meeting of Stockholders Dec 6, 2018 09:41AM
Immune Pharmaceuticals Announces Adjournment of Special Meeting of Stockholders Dec 6, 2018 09:00AM
Immune Pharmaceuticals and Vector Therapeutics Sign Option Agreement for Worldwide Ceplene® Rights Nov 27, 2018 07:30AM


Nov 19, 2018 05:53PM Immune Pharmaceuticals Reschedules Corporate Update Call
Nov 16, 2018 08:30AM Immune Pharmaceuticals Schedules Corporate Update Call
Oct 29, 2018 07:35AM Immune Pharma (IMNP) Highlights New Clinical Data from Positive, Proof-of-Concept Phase 2a Trial of Bertilimumab in Bullous Pemphigoid
Oct 29, 2018 07:30AM New Clinical Data Support Bertilimumab Activity in Bullous Pemphigoid
Oct 17, 2018 09:06AM Immune Pharma (IMNP) Reports Positive Preclinical Results in Asthma
Oct 17, 2018 09:00AM Immune Pharmaceuticals Announces Positive Preclinical Results in Asthma
Oct 10, 2018 04:30PM Immune Pharmaceuticals Announces $5 Million Financing
Jun 21, 2016 09:00AM Vista Partners Publishes June 2016 Macroeconomic & Investment Newsletter
Dec 10, 2015 01:20PM What $40 or Less Oil Means to the Economy
Nov 10, 2015 09:00AM What Summer Downturn?
Nov 2, 2015 10:30AM StockNewsNow.com Publishes Q3 2015 Review SNNLive Video Interview With Immune Pharmaceuticals, Inc.
Sep 15, 2015 12:20PM Should We Believe the Fed Will Not Raise Rates in 2015?
Jul 23, 2015 09:00AM Vista Partners Initiates Coverage on Immune Pharmaceuticals Inc. (NasdaqCM: IMNP); $6.00 Price Target
Jun 25, 2015 08:30AM StockNewsNow.com Publishes New SNNLive Video Interview With Immune Pharmaceuticals, Inc.
May 22, 2015 10:00AM Immune Pharmaceuticals Inc. (Nasdaq: IMNP) to Ring The Nasdaq Stock Market Closing Bell